期刊文献+

血清降钙素原对ICU脓毒症患者的临床意义 被引量:8

Clinical Significance of Procalcitonin for Sepsis in ICU
下载PDF
导出
摘要 目的探讨血清降钙素原(procalcitonm,PCT)对重症监护病房(ICU)脓毒症患者早期病情评估及预后的临床意义.方法回顾性分析2013年1月~2014年1月沈阳市第四人民医院ICU收治的68例脓毒症患者,其中脓毒症组30例,严重脓毒症组38例.分析比较脓毒症和严重脓毒症患者入ICU时的血清白细胞计数(white blood cell count,WBC)、C反应蛋白(c—rcactive protein,CRP)及降钙素原(PCT)水平、急性生理与慢性健康状况评分Ⅱ(APACHEⅡ评分)。结果严重脓毒症组血清WBC、CRP、PCT及APACHEⅡ评分均高于脓毒症组,两组这间存在统计学差异(均P〈0.05)。结论血清PCT对脓毒症早期诊断、监测病情有重要的临床价值。 Objective To investigate the clinical significance of procalcitonin ( PCT ) in early diagnonsis of sepsis and evaluation of prognosis in ICU. Methods P, etrospective analysis of 68 patients from January 2013 to January 2014 was performed in ICU of Shenyang The forth hospital of people including the sepsis group( 30 cases )and the sever sepsis group( 38 cases ). The data collected included blood white blood cell count( WBC ), c-reactive protein( CRP ), procalcitonin ( PCT ) and acute physiology and chronic health evaluation Ⅱ ( APACHE Ⅱ ) on the day of hospitalization in ICU. Results The level ofWBC, CRP, PCT and APACHE II score of the sever sepsis group were significantly higher than those in sepsis group, and the differences showed statistically significance ( P〈0.05 ) . Conclusion PCT indicated important clinical value for early diagnosis of sepsis and assessment of disease condition.
作者 任志慧 冯伟
出处 《中国卫生标准管理》 2015年第5期212-214,共3页 China Health Standard Management
关键词 降钙素原 脓毒症 Procalcitonin, Sepsis
  • 相关文献

参考文献10

  • 1Tschaikowsky K, Hedwig-Geissing M, Braun GG, et al. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis [J ]. . J Crit Care, 2011, 26 (1) : 54-56.
  • 2Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS. International sepsis definitions conference [J ]. . Crit Care Med, 2003, 29 (4) : 530-538.
  • 3Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in european intensive care units: Results of the SOAP study [J ]. . Crit Care Med, 2006, 34 (2) : 344-353.
  • 4Moya F, Nieto A, CandelaJL. Calcitonin biosynthesis: evidence for aprecursor [J ]. . EurJ Biochem, 1975, 55 (2) : 407-413.
  • 5Assicot M, Gendrel D, Cat,sin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection [J ]. . Lancet, 1993, 341 (8844) : 515-518.
  • 6Linscheid P, Sehoek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue [J ]. . Endocrinology, 2003, 144 ( 12 ) : 5578-5584.
  • 7Mueller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin I gene in multiple tissues in response to sepsis [J ]. . J din endocrinol metab, 2001, 86 ( 1 ) : 396-404.
  • 8Endo S, Aikawa N, Fujishima S, et al. Usefulness ofprocalcitonin serum level for the discrimination of seVere sepsis from sepsis: a multicenter prospective study[ J ]. J infect chemother, 2008, 14( 3 ): 244-249.
  • 9Uzzan B, Cohen R, Nicolas P, et at. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis[ J ]. Crit Care Med 2006, 34( 7 ): 1996-2003.
  • 10Schneider HG, Lain QT. Procalcitonin for the clinical laboratory: a review [J ]. . Pathology, 2007, 39 (4) : 383-390.

同被引文献74

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部